Newsletter Subscription

Thursday, Oct 27, 2016

Raytheon and Israel's UVision to Develop Loitering Airborne Solutions

  • Team will adapt UVision's Hero-30 system for U.S. Army requirement

Raytheon Company (NYSE: RTN) and UVision signed a teaming agreement to work together on small, loitering airborne solutions. As part of the deal, Raytheon will adapt the Hero-30 remotely-operated lethal loitering airborne system from Israel's UVision for U.S. military requirements.  

Hero-30 is a man-packed, canister-launched airborne loitering system. Raytheon will modify the Hero-30 for lethal target engagement as well as traditional airborne intelligence, surveillance and reconnaissance missions. The adapted system will meet the U.S. Army's requirement for Lethal Miniature Aerial Missile Systems, also known as LMAMS.

"Raytheon and UVision will offer U.S. Army small units a new capability with a fully-developed, portable, lethal loitering system," said Dr. Thomas Bussing, Raytheon vice president of Advanced Missile Systems. "This system significantly enhances the situational awareness and combat power of small units operating on the battlefield."

The Hero-30 derivative could fulfill conventional small-unit and special-operations requirements. Previous user evaluations have determined Hero-30 to be extremely flexible and simple to operate for small-unit operations.

"We are eager to begin work with Raytheon - one of the world's most innovative technology and defense companies. The Hero-30 plays a significant role for ground forces regardless of the operating environment," said Noam Levitt, UVision chief executive officer. "Our partnership with Raytheon provides valuable battlefield intelligence and the capability to directly engage enemy threats when necessary."

Source : Raytheon Corporation (NYSE: RTN) - view original press release

Published on ASDNews: May 27, 2016


Future Armoured Vehicles Survivability Conference

Nov 23 - 24, 2016 - London, United Kingdom

Register More info

Surface Warships Conference

Jan 24 - 26, 2017 - London, United Kingdom

Register More info

© 2004-2016 • ASDNews • be the first to know • contact usterms & conditionsprivacy policyadvertisingfaqs